Clinical Trial Update: Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled Trial [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a randomized Phase 1/2 trial evaluating inhaled nitric oxide as adjunctive therapy for severe malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Severe Malaria | Phase 1, Phase 2 | Status: COMPLETED